Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Ng, Enders K O ^a,b   Leung, Candy P H ^a   Shin, Vivian Y ^a   Wong, Chris L P ^b,d   Ma, Edmond S K ^b,d   Jin, Hong Chuan ^c   Chu, Kent Man ^a   Kwong, Ava ^a,b,d,e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^c ZHEJIANG UNIVERSITY   (China)

^d Hong Kong Hereditary Breast Cancer Family Registry ^*  (China)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED FOLATE CARRIER; SOLUTE CARRIER FAMILY 19 MEMBER 3; TUMOR MARKER; UNCLASSIFIED DRUG; CARRIER PROTEIN; SLC19A3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CHINESE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA METHYLATION; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION SENSITIVE RESTRICTION ENZYME DIGESTION; PREDICTIVE VALUE; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SLC19A3 GENE; STOMACH CANCER; VALIDATION STUDY; BLOOD; BREAST TUMOR; DOWN REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; ROC CURVE; STOMACH NEOPLASMS;

EID: 79960611738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022233     Document Type: Article

References (21)

1. Egger G, Liang G, Aparicio A, Jones PA, (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463.
2. Rashid A, Issa JP, (2004) CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology 127: 1578-1588.
3. Widschwendter M, Jones PA, (2002) DNA methylation and breast carcinogenesis. Oncogene 21: 5462-5482.
4. Widschwendter A, Muller HM, Fiegl H, Ivarsson L, Wiedemair A, et al. (2004) DNA methylation in serum and tumors of cervical cancer patients. Clin Cancer Res 10: 565-571.
5. Widschwendter M, Menon U, (2006) Circulating methylated DNA: a new generation of tumor markers. Clin Cancer Res 12: 7205-7208.
6. Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, et al. (2005) Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res 65: 1141-1145.
7. Gal S, Fidler C, Lo YM, Taylor M, Han C, et al. (2004) Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. Br J Cancer 90: 1211-1215.
8. Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, et al. (2008) Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J Gastroenterol 14: 3074-3080.
9. Muller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, et al. (2003) DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 63: 7641-7645.
10. Liu X, Lam EK, Wang X, Zhang J, Cheng YY, et al. (2009) Promoter Hypermethylation Mediates Downregulation of Thiamine Receptor SLC19A3 in Gastric Cancer. Tumour Biol 30: 242-248.
11. Liu S, Huang H, Lu X, Golinski M, Comesse S, et al. (2003) Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. Mol Cancer Res 1: 665-673.
12. Liu S, Stromberg A, Tai HH, Moscow JA, (2004) Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells. Mol Cancer Res 2: 477-487.
13. Ganapathy V, Smith SB, Prasad PD, (2004) SLC19: the folate/thiamine transporter family. Pflugers Arch 447: 641-646.
14. Rajgopal A, Edmondnson A, Goldman ID, Zhao R, (2001) SLC19A3 encodes a second thiamine transporter ThTr2. Biochim Biophys Acta 1537: 175-178.
15. Eudy JD, Spiegelstein O, Barber RC, Wlodarczyk BJ, Talbot J, et al. (2000) Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. Mol Genet Metab 71: 581-590.
16. Lee BY, Yanamandra K, Bocchini JA Jr, (2005) Thiamin deficiency: a possible major cause of some tumors? (review). Oncol Rep 14: 1589-1592.
17. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, et al. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32.
18. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381.
19. Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, et al. (2003) Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem 49: 719-726.
20. Chiu RW, Lui WB, El-Sheikhah A, Chan AT, Lau TK, et al. (2005) Comparison of protocols for extracting circulating DNA and RNA from maternal plasma. Clin Chem 51: 2209-2210.
21. Reidling JC, Lambrecht N, Kassir M, Said HM, (2010) Impaired intestinal vitamin B1 (thiamin) uptake in thiamin transporter-2-deficient mice. Gastroenterology 138: 1802-1809.